Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 4
Background: Telogen effluvium (TE) after COVID-19 infection or vaccination is a common sequelae in dermatology clinics. Objective: to study the prevalence of telogen effluvium in COVID-19 patients and its association with COVID vaccine. Methods: Cross-sectional study via online questionnaire in Saudi Arabia and other Arabic countries.